Closed · RFA-TS-24-010 · CFDA 93.061 · Discretionary
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- up to $500K
- Award range
- Closed
- Status
- December 19, 2023
- Close date
- 8
- Expected awards
The verdict
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Up to $500,000 across 8 expected awards. Future funding cycles may be published under the same CFDA number.
- up to $500K
- award range
- Closed
- application status
- 8
- expected awards
- 93.061
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) - is cataloged under number RFA-TS-24-010 and tied to CFDA assistance listing 93.061, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on August 1, 2023 and last updated on November 20, 2023. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Up to $500,000. The agency has projected $7.5 million in total estimated funding for this announcement. It expects to issue 8 awards. If the agency funds the expected 8 awards from the $7.5 million estimated pool, the average award works out to roughly $938,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on December 19, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Up to $500,000
Close Date
December 19, 2023
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Posted
August 1, 2023
Est. Total Funding
$7,500,000
Expected Awards
8
Instrument
Grant
Description
The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will further the understanding of potential risk factors for Amyotrophic Lateral Sclerosis (ALS), while supporting the National ALS Registry's mission. The National ALS Registry's goals are to estimate the number of new ALS cases each year, estimate the number of people who have ALS at a specific point in time, better understand who gets ALS, and identify what contributing factors, including environmental, may affect ALS. CDC/ATSDR is seeking investigator-initiated research that will identify and evaluate risk factors contributing to ALS, with preferred focus in this Notice of Funding Opportunity on factors related to military service, contact sports, traumatic brain injury, neuroinflammation, environmental exposures, and infectious agents. Research proposals on preferred topics can be funded under one of two funding options, Funding Option A or Funding Option B.Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base foundation base, may be supported by limited and insufficient preliminary research, and are exploratory and developmental in nature.For Option A and B applicants may elect to use data from the National ALS Registry. Note, this is not compulsory and will not preclude the applicant from consideration.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Candis M. Hunter, PhD, MSPH, REHS/RS ncipc_erpo@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
RFA-IP-18-000
RFA-CC-18-000
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |